StockData
Alkermes plc. logo

Alkermes plc. (ALKS) stock

ALKSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30208% above fair value
$45.45−1.08 (-2.32%)

Close on Nov 17, 2026Market cap $7.62BP/E 119.6Yield –

Alkermes shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Alkermes's shares outstanding was 173M at Jun 30, 2026. For fiscal 2025 it was 169M, down 0.3% from the year before. Over ten years it grew 1.2% a year on average. The highest annual figure on record is 170M in fiscal 2023.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 2025169M-0.3%
FY2024Dec 31, 2024169M-0.3%
FY2023Dec 31, 2023170M+3.7%
FY2022Dec 31, 2022164M-0.6%
FY2021Dec 31, 2021165M+3.7%
FY2020Dec 31, 2020159M+1.1%
FY2019Dec 31, 2019157M+1.3%
FY2018Dec 31, 2018155M+1.1%
FY2017Dec 31, 2017153M+1.3%
FY2016Dec 31, 2016151M+1.5%
FY2015Dec 31, 2015149M+8.8%
FY2013Mar 31, 2013137M+19.5%
FY2012Mar 31, 2012115M+20.0%
FY2011Mar 31, 201196M+0.8%
FY2010Mar 31, 201095M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026173M+3.0%
Q1 FY2026Mar 31, 2026166M-1.5%
Q4 FY2025Dec 31, 2025170M+2.1%
Q3 FY2025Sep 30, 2025169M+0.9%
Q2 FY2025Jun 30, 2025168M-1.5%
Q1 FY2025Mar 31, 2025169M-2.5%
Q4 FY2024Dec 31, 2024166M+0.1%
Q3 FY2024Sep 30, 2024167M-2.8%
Q2 FY2024Jun 30, 2024171M-0.3%
Q1 FY2024Mar 31, 2024173M+4.8%
Q4 FY2023Dec 31, 2023166M+1.0%
Q3 FY2023Sep 30, 2023172M+4.6%
Q2 FY2023Jun 30, 2023172M+4.7%
Q1 FY2023Mar 31, 2023165M+1.6%
Q4 FY2022Dec 31, 2022164M-7.2%
Q3 FY2022Sep 30, 2022164M+1.8%
Q2 FY2022Jun 30, 2022164M-0.1%
Q1 FY2022Mar 31, 2022162M+1.8%
Q4 FY2021Dec 31, 2021177M+11.3%
Q3 FY2021Sep 30, 2021161M+1.5%
Q2 FY2021Jun 30, 2021164M+3.2%
Q1 FY2021Mar 31, 2021160M+1.0%
Q4 FY2020Dec 31, 2020159M+0.9%
Q3 FY2020Sep 30, 2020159M+1.2%
Q2 FY2020Jun 30, 2020159M+1.2%
Q1 FY2020Mar 31, 2020158M+1.1%
Q4 FY2019Dec 31, 2019158M+1.4%
Q3 FY2019Sep 30, 2019157M+1.2%
Q2 FY2019Jun 30, 2019157M+1.2%
Q1 FY2019Mar 31, 2019156M+1.2%
Q4 FY2018Dec 31, 2018156M+1.1%
Q3 FY2018Sep 30, 2018155M+1.1%
Q2 FY2018Jun 30, 2018155M+1.2%
Q1 FY2018Mar 31, 2018154M+1.1%
Q4 FY2017Dec 31, 2017154M+1.1%
Q3 FY2017Sep 30, 2017154M+1.3%
Q2 FY2017Jun 30, 2017153M–
Q1 FY2017Mar 31, 2017153M–
Q4 FY2016Dec 31, 2016152M–
Q3 FY2016Sep 30, 2016152M–

More Alkermes figures

See a number that looks wrong?